We are currently updating this website.

Olerup QTYPE® receives CE/IVD certification

Published: 2018-04-13

Olerup QTYPE® receives CE/IVD certification

CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, announced today that Olerup QTYPE, the fastest real time Human Leukocyte Antigen (HLA) typing diagnostic, has received CE Mark approval.

For more information on Olerup QTYPE, please click on the Product tab above or contact your CareDx representative.